Predictors and Prognostic Impact of Hematoma Expansion in Infratentorial Cerebral Hemorrhage.

Hypodensity Infratentorial Intracerebral hemorrhage Noncontrast computed tomography Stroke

Journal

Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086

Informations de publication

Date de publication:
05 Sep 2023
Historique:
received: 01 02 2023
accepted: 24 07 2023
medline: 5 9 2023
pubmed: 5 9 2023
entrez: 4 9 2023
Statut: aheadofprint

Résumé

Hematoma expansion (HE) is common and predicts poor outcome in patients with supratentorial intracerebral hemorrhage (ICH). We investigated the predictors and prognostic impact of HE in infratentorial ICH. We conducted a retrospective analysis of patients with brainstem and cerebellar ICH admitted at seven sites. Noncontrast computed tomography images were analyzed for the presence of hypodensities according to validated criteria, defined as any hypodense region strictly encapsulated within the hemorrhage with any shape, size, and density. Occurrence of HE (defined as > 33% and/or > 6-mL growth) and mortality at 90 days were the outcomes of interest. Their predictors were investigated using logistic regression with backward elimination at p < 0.1. Logistic regression models for HE were adjusted for baseline ICH volume, antiplatelet and anticoagulant treatment, onset to computed tomography time, and presence of hypodensities. The logistic regression model for mortality accounted for the ICH score and HE. A total of 175 patients were included (median age 75 years, 40.0% male), of whom 38 (21.7%) had HE and 43 (24.6%) died within 90 days. Study participants with HE had a higher frequency of hypodensities (44.7 vs. 24.1%, p = 0.013), presentation within 3 h from onset (39.5 vs. 24.8%, p = 0.029), and 90-day mortality (44.7 vs. 19.0%, p = 0.001). Hypodensities remained independently associated with HE after adjustment for confounders (odds ratio 2.44, 95% confidence interval 1.13-5.25, p = 0.023). The association between HE and mortality remained significant in logistic regression (odds ratio 3.68, 95% confidence interval 1.65-8.23, p = 0.001). Early presentation and presence of noncontrast computed tomography hypodensities were independent predictors of HE in infratentorial ICH, and the occurrence of HE had an independent prognostic impact in this population.

Sections du résumé

BACKGROUND BACKGROUND
Hematoma expansion (HE) is common and predicts poor outcome in patients with supratentorial intracerebral hemorrhage (ICH). We investigated the predictors and prognostic impact of HE in infratentorial ICH.
METHODS METHODS
We conducted a retrospective analysis of patients with brainstem and cerebellar ICH admitted at seven sites. Noncontrast computed tomography images were analyzed for the presence of hypodensities according to validated criteria, defined as any hypodense region strictly encapsulated within the hemorrhage with any shape, size, and density. Occurrence of HE (defined as > 33% and/or > 6-mL growth) and mortality at 90 days were the outcomes of interest. Their predictors were investigated using logistic regression with backward elimination at p < 0.1. Logistic regression models for HE were adjusted for baseline ICH volume, antiplatelet and anticoagulant treatment, onset to computed tomography time, and presence of hypodensities. The logistic regression model for mortality accounted for the ICH score and HE.
RESULTS RESULTS
A total of 175 patients were included (median age 75 years, 40.0% male), of whom 38 (21.7%) had HE and 43 (24.6%) died within 90 days. Study participants with HE had a higher frequency of hypodensities (44.7 vs. 24.1%, p = 0.013), presentation within 3 h from onset (39.5 vs. 24.8%, p = 0.029), and 90-day mortality (44.7 vs. 19.0%, p = 0.001). Hypodensities remained independently associated with HE after adjustment for confounders (odds ratio 2.44, 95% confidence interval 1.13-5.25, p = 0.023). The association between HE and mortality remained significant in logistic regression (odds ratio 3.68, 95% confidence interval 1.65-8.23, p = 0.001).
CONCLUSION CONCLUSIONS
Early presentation and presence of noncontrast computed tomography hypodensities were independent predictors of HE in infratentorial ICH, and the occurrence of HE had an independent prognostic impact in this population.

Identifiants

pubmed: 37667076
doi: 10.1007/s12028-023-01819-w
pii: 10.1007/s12028-023-01819-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.

Références

van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167–76.
doi: 10.1016/S1474-4422(09)70340-0 pubmed: 20056489
Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score. Stroke. 2001;32(4):891–7.
doi: 10.1161/01.STR.32.4.891 pubmed: 11283388
Zahuranec DB, Brown DL, Lisabeth LD, et al. Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology. 2007;68(20):1651–7.
doi: 10.1212/01.wnl.0000261906.93238.72 pubmed: 17502545
Brouwers HB, Greenberg SM. Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis. 2013;35(3):195–201.
doi: 10.1159/000346599 pubmed: 23466430
Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66(8):1175–81.
doi: 10.1212/01.wnl.0000208408.98482.99 pubmed: 16636233
Delcourt C, Huang Y, Arima H, et al. Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology. 2012;79(4):314–9.
doi: 10.1212/WNL.0b013e318260cbba pubmed: 22744655
Delcourt C, Sato S, Zhang S, et al. Intracerebral hemorrhage location and outcome among INTERACT2 participants. Neurology. 2017;88(15):1408–14.
doi: 10.1212/WNL.0000000000003771 pubmed: 28235817 pmcid: 5386433
Qureshi AI. Antihypertensive treatment of acute cerebral hemorrhage (ATACH): rationale and design. Neurocrit Care. 2007;6(1):56–66.
doi: 10.1385/NCC:6:1:56 pubmed: 17356194
Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011;15(3):559–76.
doi: 10.1007/s12028-011-9538-3 pubmed: 21626077 pmcid: 3340125
Boulouis G, Morotti A, Brouwers HB, et al. Association between hypodensities detected by computed tomography and hematoma expansion in patients with intracerebral hemorrhage. JAMA Neurol. 2016;73(8):961–8.
doi: 10.1001/jamaneurol.2016.1218 pubmed: 27323314 pmcid: 5584601
Boulouis G, Morotti A, Charidimou A, Dowlatshahi D, Goldstein JN. Noncontrast computed tomography markers of intracerebral hemorrhage expansion. Stroke. 2017;48(4):1120–5.
doi: 10.1161/STROKEAHA.116.015062 pubmed: 28289239 pmcid: 5378158
Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108–29.
doi: 10.1161/STR.0b013e3181ec611b pubmed: 20651276 pmcid: 4462131
Hemphill JC, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60.
doi: 10.1161/STR.0000000000000069 pubmed: 26022637
Al-Shahi Salman R, Frantzias J, Lee RJ, et al. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data. Lancet Neurol. 2018;17(10):885–94.
doi: 10.1016/S1474-4422(18)30253-9 pubmed: 30120039 pmcid: 6143589
Morotti A, Boulouis G, Dowlatshahi D, et al. Standards for detecting, interpreting, and reporting noncontrast computed tomographic markers of intracerebral hemorrhage expansion. Ann Neurol. 2019;86(4):480–92.
doi: 10.1002/ana.25563 pubmed: 31364773
Dowlatshahi D, Morotti A, Al-Ajlan FS, et al. Interrater and intrarater measurement reliability of noncontrast computed tomography predictors of intracerebral hemorrhage expansion. Stroke. 2019;50(5):1260–2.
doi: 10.1161/STROKEAHA.118.024050 pubmed: 30909839
Nawabi J, Elsayed S, Kniep H, et al. Inter-and intrarater agreement of spot sign and noncontrast CT markers for early intracerebral hemorrhage expansion. J Clin Med. 2020;9(4):1–10.
doi: 10.3390/jcm9041020
Dowlatshahi D, Demchuk AM, Flaherty ML, et al. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011;76(14):1238–44.
doi: 10.1212/WNL.0b013e3182143317 pubmed: 21346218 pmcid: 3068004
Singh SD, Pasi M, Schreuder FHBM, et al. Computed tomography angiography spot sign, hematoma expansion, and functional outcome in spontaneous cerebellar intracerebral hemorrhage. Stroke. 2021;52(9):2902–9.
doi: 10.1161/STROKEAHA.120.033297 pubmed: 34126759
New PF, Aronow S. Attenuation measurements of whole blood and blood fractions in computed tomography. Radiology. 1976;121(3 Pt. 1):635–40.
doi: 10.1148/121.3.635 pubmed: 981659
Chu H, Huang C, Dong J, Dong Q, Tang Y. Absolute hypodensity sign by noncontrast computed tomography as a reliable predictor for early hematoma expansion. Brain Hemorrhages. 2020;1(3):152–7.
doi: 10.1016/j.hest.2020.07.003
Morotti A, Boulouis G, Dowlatshahi D, et al. Intracerebral haemorrhage expansion: definitions, predictors, and prevention. Lancet Neurol. 2023;22(2):159–71.
doi: 10.1016/S1474-4422(22)00338-6 pubmed: 36309041
Teo KC, Fong SM, Leung WCY, et al. Location-specific hematoma volume cutoff and clinical outcomes in intracerebral hemorrhage. Stroke. 2023;54(6):1548–57.
doi: 10.1161/STROKEAHA.122.041246 pubmed: 37216445 pmcid: 10266339
Parry-Jones AR, Sammut-Powell C, Paroutoglou K, et al. An intracerebral hemorrhage care bundle is associated with lower case fatality. Ann Neurol. 2019;86(4):495–503.
doi: 10.1002/ana.25546 pubmed: 31291031 pmcid: 6771716
Arba F, Rinaldi C, Boulouis G, Fainardi E, Charidimou A, Morotti A. Noncontrast computed tomography markers of cerebral hemorrhage expansion: diagnostic accuracy meta-analysis. Int J Stroke. 2022;17(8):835–47.
doi: 10.1177/17474930211061639
Shah VA, Thompson RE, Yenokyan G, et al. One-year outcome trajectories and factors associated with functional recovery among survivors of intracerebral and intraventricular hemorrhage with initial severe disability. JAMA Neurol. 2022;79(9):856–68.
doi: 10.1001/jamaneurol.2022.1991 pubmed: 35877105 pmcid: 9316056

Auteurs

Debora Pezzini (D)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Piazzale Spedali Civili, 1, 25123, Brescia, Italy. d.pezzini@unibs.it.

Jawed Nawabi (J)

Department of Radiology (CCM), Charité-Universitätsmedizin Berlin, Campus Mitte, Berlin Institute of Health, Humboldt-Universitätzu Berlin, FreieUniversität Berlin, Berlin, Germany.
Berlin Institute of Health (BIH), BIH Biomedical Innovation Academy, Berlin, Germany.

Frieder Schlunk (F)

Berlin Institute of Health (BIH), BIH Biomedical Innovation Academy, Berlin, Germany.
Department of Neuroradiology, Charité-Universitätsmedizin Berlin, FreieUniversität Berlin, Humboldt-Universitätz Berlin, Berlin, Germany.

Qi Li (Q)

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Federico Mazzacane (F)

U.C. Malattie Cerebrovascolari e Stroke Unit, IRCCS Fondazione Mondino, Pavia, Italy.

Giorgio Busto (G)

Neuroradiology Unit, Department of Radiology, Careggi University Hospital, Florence, Italy.

Elisa Scola (E)

Neuroradiology Unit, Department of Radiology, Careggi University Hospital, Florence, Italy.

Francesco Arba (F)

Stroke Unit, Careggi University Hospital, Florence, Italy.

Laura Brancaleoni (L)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna, Italy.

Sebastiano Giacomozzi (S)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna, Italy.

Luigi Simonetti (L)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UO (SSI) di Neuroradiologia, Ospedale Maggiore, Bologna, Italy.

Michele Laudisi (M)

Clinica Neurologica, Dipartimento di Scienze Biomediche e Chirurgico Specialistiche, Università degli Studi di Ferrara, Ospedale Universitario S. Anna, Ferrara, Italy.

Anna Cavallini (A)

U.C. Malattie Cerebrovascolari e Stroke Unit, IRCCS Fondazione Mondino, Pavia, Italy.

Aristeidis H Katsanos (AH)

Division of Neurology, McMaster University/Population Health Research Institute, Hamilton, ON, Canada.
Second Department of Neurology, Attikon Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Ashkan Shoamanesh (A)

Division of Neurology, McMaster University/Population Health Research Institute, Hamilton, ON, Canada.

Andrea Zini (A)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna, Italy.

Ilaria Casetta (I)

Clinica Neurologica, Dipartimento di Scienze Biomediche e Chirurgico Specialistiche, Università degli Studi di Ferrara, Ospedale Universitario S. Anna, Ferrara, Italy.

Enrico Fainardi (E)

Neuroradiology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.

Andrea Morotti (A)

Neurology Unit, Department of Neurological Sciences and Vision, ASST Spedali Civili, Brescia, Italy.

Alessandro Padovani (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Piazzale Spedali Civili, 1, 25123, Brescia, Italy.
Neurology Unit, Department of Neurological Sciences and Vision, ASST Spedali Civili, Brescia, Italy.

Classifications MeSH